OrganaBio

The Blood and Cells Ambassadors Register (BCAR) brought together some of the biggest voices in the blood industry to discuss the many issues facing the blood sector today, including the #ethics of blood donorship, maintaining quality, and repeatability of blood and cells in starting materials. The Pathologist article dives into the challenges surrounding blood donation, discussing how to ensure quality and consistent supply of blood and blood products. Priya Baraniak, Ph.D. shares OrganaBio's stance on the ethics and future of blood donations: https://lnkd.in/eTAfMhpM #blooddonation #celltherapy #genetherapy #immunotherapy

Cutting-edge FDA-approved therapies made from human cells are now being used to treat cancer, diabetes, and other diseases. Currently, most approved cell-based therapies use an individual's own cells, but the next generation of these therapies will be made from donor-derived blood and tissue. That raises critical questions about how to recruit, retain, and fairly compensate donors while ensuring their safety throughout the donation process. The industry must demonstrate ethical leadership on behalf of donors while regulators develop clearer and better-harmonized rules. Read more about the ethical considerations of allogeneic cell therapy and its donors in STAT by Priya Baraniak, Ph.D. #ethics #celltherapy #genetherapy #cgt #cellandgenetherapy

At BIO 2024, Priya Baraniak, Ph.D., highlighted bottlenecks that make #celltherapies inaccessible to many patients. She emphasized the need for creative partnerships and solutions to reduce development time, production costs, and patient access limitations. Continue reading here: https://lnkd.in/gF6KuAgm #cgt #celltherapy #genetherapy #regenerativemedicine #cancerresearch #immunotherapy

As a Women in Advanced Therapies founding member, OrganaBio is proud to have Priya Baraniak, Ph.D. host a panel discussion during #WIAT Global event on Wednesday, July 10th, at 3pm EST. Unlock 24 hours of exclusive, content-rich sessions featuring the latest breakthroughs and innovations in cell and gene therapy, presented by industry leaders and experts: https://lnkd.in/eBC7Tn7V #WomenInSTEM #advancedtherapies #cgt #celltherapy #genetherapy

Happy 4th of July from the OrganaBio family to yours.

In this Pharma's Almanac article, industry leaders discuss the investment trends that are shaping the future of discoveries and treatments. The pharmaceutical industry is seeing a shift in investment focus, driving exciting innovation as more funding fuels groundbreaking next-generation biologics, gene editing, and mRNA vaccines that will transform the future medicine. Read Priya Baraniak, Ph.D.'s take on this topic here: https://lnkd.in/g3C3Dj7B #cgt #celltherapy #genetherapy #immunotherapy #vaccine #pharma #cancerresearch

In the pursuit of excellence in #celltherapy, OrganaBio is committed to maintaining the highest standards for apheresis-derived #PBMC quality and cryopreservation. Every step of our process adheres to approved SOPs and MBRs, documented in our eQMS, and released after review by Quality and the Lab Director. Contact us for a sample CoA at sales@organabio.com #cgt #leukopak #cryopreservation #immunotherapy #biotechnology

The #pharma industry is undergoing a digital revolution and solution providers have a key role to play in helping companies achieve more connected operations. At OrganaBio, we utilize digital solutions to streamline data and operations and expedite processes while maintaining data integrity and security. Read more about what industry SME like Priya Baraniak, Ph.D. are saying about the transition to more digital operations in the latest Pharma's Almanac round table: https://lnkd.in/gxZTgyu5 #digitalhealth #innovation #cgt #celltherapy #immunotherapy

On Juneteenth, we recognize the emancipation of enslaved people in the United States. We also acknowledge that the fight for true equality and justice continues. OrganaBio stands in solidarity with those working to dismantle systemic racism and other forms of discrimination to create a more equitable society for all. #juneteenth #freedom #equality #justice

OrganaBio’s GMP-compliant Hematopoietic Stem Cells are specifically designed for next-generation #celltherapy development. · Isolated from fresh CBU collected immediately after birth · Processed in ISO 7 cleanroom under approved SOPs and MBRs using GMP-compliant materials and reagents · Governed by and documented in OrganaBio’s eQMS and released by Medical Director, Lab Director, QC, and QA -> Request a quote:sales@organabio.com #hsc #stemcells #cgt #immunotherapy #genetherapy #regenerativemedicine